Stockreport

Puma Biotechnology: A Story In Flux Heading Into Mid-2024 [Seeking Alpha]

Puma Biotechnology Inc  (PBYI) 
Last puma biotechnology inc earnings: 2/20 04:07 pm Check Earnings Report
US:NYSE Investor Relations: pumabiotechnology.com/ir.html
PDF The company's lone approved product, neratinib, is being marketed for HER2-positive breast cancer, but competition in the HER2 space is fierce. Puma Biotechnology's f [Read more]